News | January 06, 2026
Dabur sees early demand recovery, rural sales lead growth in Q3 FY26
Within India, Dabur expects its Home & Personal Care business to deliver double-digit growth,
Within India, Dabur expects its Home & Personal Care business to deliver double-digit growth,
The company previously completed a $150 million venture investment, acquisition, and recapitalization
India’s traditional medicine systems have also earned formal recognition in key bilateral trade agreements
Syrma Johari is a globally recognised medical device engineering and manufacturing organisation
His professional background also includes key experience at Matrix Labs and Sun Pharma
The portfolio, purchased from a leading multinational generic manufacturer, addresses a market valued at $473.2 million for the 12 months ending August 2025
Cupid is strengthening its footprint in the GCC region, focusing on supply responsiveness and market proximity
The decision secures legal protection in China for semaglutide, the blockbuster drug underpinning Novo Nordisk’s diabetes and obesity treatments
Applications include detailed scientific rationale and supporting clinical evidence
The plant is expected to enhance regional supply capabilities
Subscribe To Our Newsletter & Stay Updated
